31 Oct 2024
// FIERCE PHARMA
30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// REUTERS
01 10AbbVie Bioresearch Center, Inc.
02 1AbbVie Clinical Pharmacology Research Unit (ACPRU)
03 5AbbVie Deutschland GmbH & Co. KG
04 5AbbVie Inc
05 34AbbVie Inc.
06 2AbbVie Medical Device Center
07 8Abbvie Biotechnology Ltd.
08 5Abbvie Ireland NL B.V.
09 15Abbvie LTD
10 1Abbvie Operations Singapore Pte Ltd
11 5Abbvie SRL
12 5Fournier Laboratories Ireland, Ltd. (Abbvie Cork)
01 52No Action Indicated
02 44Voluntary Action Indicated
01 22023-01-31
02 12022-10-06
03 12022-05-20
04 12021-12-15
05 12020-02-28
06 12020-02-20
07 12020-01-10
08 12019-11-18
09 12019-08-29
10 12019-07-19
11 12019-05-10
12 12019-03-25
13 12019-02-15
14 12019-02-12
15 12018-12-21
16 12018-11-23
17 12018-11-16
18 12018-11-15
19 22018-08-24
20 12018-07-02
21 12018-06-01
22 12018-05-24
23 12018-02-16
24 22017-12-15
25 12017-12-14
26 12017-11-21
27 12017-04-28
28 12017-04-11
29 12017-01-27
30 12017-01-20
31 12016-07-29
32 12016-07-13
33 12016-04-20
34 12016-03-24
35 12016-02-04
36 22015-12-16
37 12015-10-23
38 12015-10-09
39 22015-08-06
40 12015-06-11
41 22014-12-16
42 12014-11-18
43 12014-09-29
44 12014-09-26
45 12014-09-18
46 12014-09-12
47 12014-09-05
48 12014-07-16
49 12014-06-06
50 12014-05-20
51 12014-04-03
52 22013-12-13
53 12013-09-04
54 22013-04-25
55 22013-03-01
56 12012-12-07
57 12012-12-04
58 12012-10-25
59 12012-08-09
60 12012-07-12
61 12012-03-29
62 22011-12-22
63 12011-10-20
64 12011-07-13
65 12011-07-12
66 12011-04-29
67 12011-04-01
68 12011-03-24
69 12011-03-14
70 12010-10-28
71 12010-10-15
72 12010-06-01
73 22010-02-01
74 12010-01-21
75 12009-12-17
76 12009-06-12
77 12009-06-11
78 12009-05-22
79 12009-05-15
80 12009-04-23
81 12009-03-30
82 12009-03-06
83 12009-03-04
84 12009-02-26
85 12009-01-16
01 6Aprilia
02 23Barceloneta
03 5Carrigtwohill
04 1Grayslake
05 5Ludwigshafen
06 33North Chicago
07 1Singapore
08 5Sligo
09 2Waukegan
10 10Worcester
11 5Wyandotte
01 5DE
02 10IE
03 6IT
04 1SG
05 74US
District Decision : No Action Indicated
Inspection End Date : 2009-03-04
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2009-03-04
District Decision : No Action Indicated
Inspection End Date : 2020-01-10
City : Grayslake
State : IL
Country/Area : US
Zip : 60030-3910
District : CHI
Center : CDER
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2020-01-10
District Decision : No Action Indicated
Inspection End Date : 2019-11-18
City : Worcester
State : MA
Country/Area : US
Zip : 01605-4312
District : NWE
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2019-11-18
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-03-25
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-03-25
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-06-01
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-06-01
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-04-28
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-04-28
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-03-24
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-03-24
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-07-16
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-07-16
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-07-12
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-07-12
District Decision : Voluntary Action Indicated
Inspection End Date : 2011-04-29
City : Barceloneta
State : PR
Country/Area : US
Zip : 00617
District : SJN
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2011-04-29
Abbvie Inc is a supplier offers 12 products (APIs, Excipients or Intermediates).
Find a price of Cyclosporine bulk with DMF, CEP offered by Abbvie Inc
Find a price of Erythromycin bulk with DMF, CEP offered by Abbvie Inc
Find a price of Biperiden Hydrochloride bulk with CEP offered by Abbvie Inc
Find a price of Butorphanol Tartrate bulk with DMF offered by Abbvie Inc
Find a price of Erythromycin Ethyl Succinate bulk with DMF offered by Abbvie Inc
Find a price of Erythromycin Stearate bulk with DMF offered by Abbvie Inc
Find a price of Isoflurane bulk with CEP offered by Abbvie Inc
Find a price of Paricalcitol bulk with DMF offered by Abbvie Inc
Find a price of Ritonavir bulk with CEP offered by Abbvie Inc
Find a price of Divalproex Sodium bulk offered by Abbvie Inc
Find a price of Enflurane bulk offered by Abbvie Inc
Find a price of Erythromycin Thiocyanate bulk offered by Abbvie Inc
LOOKING FOR A SUPPLIER?